At a glance

ClinicalIndex Comparison Record

Phase 3Completed

Drug / intervention

angioplasty, transluminal, percutaneous coronary +1 moreprocedure

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000462

NCT00000462Phase 3Completed

Compare CT.gov

Bypass Angioplasty Revascularization Investigation (BARI)

National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated May 13, 2016

In Brief

A Phase 3 clinical trial evaluating angioplasty, transluminal, percutaneous coronary and coronary artery bypass for Angina Pectoris and 5 related conditions. Completed.

Detailed Summary

To assess the relative long-term safety and efficacy of percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass graft (CABG) surgery in patients with multivessel disease and severe angina or ischemia who required revascularization and had coronary anatomy suitable for either procedure.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsAngina Pectoris, Cardiovascular Diseases, Coronary Disease, Diabetes Mellitus, Heart Diseases, Myocardial Ischemia

Countries--

Collaborators--

Timeline

Phase 3CompletedFinished

19871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Enrollment StartApr 1987

First PostedOct 1999

Study CompletionNov 2004

TodayJul 2026

First PostedOct 28, 1999

Enrollment StartApr 1, 1987

Study CompletionNov 1, 2004

TodayJul 2, 2026

Posted 26.7 years ago

Interventions

angioplasty, transluminal, percutaneous coronaryprocedure

coronary artery bypassprocedure